BROMURO DE PANCURONIO PDF

Bromuro de Pancuronio by Gripe, released 23 October List of Drug Master Files (DMF) of Bromuro de pancuronio Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data: FDA Website. bromure de pancuronium, ChemIDplus. bromuro de pancuronio, ChemIDplus. pancuronii bromidum, ChemIDplus. pancuronium bromide.

Author: Faugul Votaxe
Country: Sweden
Language: English (Spanish)
Genre: Sex
Published (Last): 14 September 2012
Pages: 327
PDF File Size: 6.23 Mb
ePub File Size: 6.97 Mb
ISBN: 540-1-23296-805-5
Downloads: 89722
Price: Free* [*Free Regsitration Required]
Uploader: Malasida

Chlorzoxazone The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Pancuronium. Bentazepam The risk or severity of adverse effects can be increased when Pancuronium is combined with Bentazepam.

Pancuronio bromuro –

Arecoline The risk or severity of adverse effects can be increased when Pancuronium is combined pqncuronio Arecoline. Naronapride The ds or severity of adverse effects can be increased when Pancuronium is combined with Naronapride. Disopyramide The therapeutic efficacy of Disopyramide can be decreased when used in combination with Pancuronium. Efonidipine Efonidipine may increase the neuromuscular blocking activities of Pancuronium.

Metyrosine Pancuronium may increase the sedative activities of Metyrosine. Bambuterol The therapeutic efficacy of Pancuronium can be decreased when used in combination with Bambuterol.

Azlocillin The therapeutic efficacy of Pancuronium can be increased when used in combination with Azlocillin. Ouabain The risk or severity of Cardiac Arrhythmia can be increased when Pancuronium is combined with Ouabain. Bromocriptine The risk or severity of adverse effects can be increased when Pancuronium is combined with Bromocriptine. Diphenhydramine The therapeutic efficacy of Diphenhydramine can be decreased when used in combination with Pancuronium. Esketamine The risk or severity of Tachycardia can be increased when Pancuronium is combined with Esketamine.

  GALILEO COMPUTING OPENBOOK PDF

Orphenadrine Pancuronium may increase the central nervous system depressant CNS depressant activities of Orphenadrine. Levosalbutamol The risk or severity of Tachycardia can be increased when Pancuronium is combined with Levosalbutamol.

Moclobemide The risk or severity of adverse effects can be increased when Moclobemide is combined pancutonio Pancuronium. Gitoformate The risk or severity of Cardiac Arrhythmia can be increased when Pancuronium is combined with Gitoformate.

Pancuronium

Fenozolone The risk or severity of Tachycardia can be increased when Pancuronium is combined with Fenozolone. Lancuronio The therapeutic efficacy of Pancuronium can be increased when used in combination with Lorpiprazole. Diphemanil Methylsulfate The therapeutic efficacy of Diphemanil Methylsulfate can be decreased when used in combination with Pancuronium.

Magnesium hydroxide The therapeutic efficacy of Pancuronium can be increased when used in combination with Magnesium hydroxide. Ibipinabant The risk or severity of Tachycardia and drowsiness can be increased when Pancuronium is combined with Ibipinabant.

Fexofenadine The risk or severity of adverse effects can be increased when Fexofenadine is combined with Pancuronium. Nalbuphine The risk or severity of adverse effects can be increased when Nalbuphine is combined with Pancuronium. Lithium cation The therapeutic efficacy of Pancuronium can be increased when used in combination with Lithium cation. Octopamine The risk or severity of Tachycardia can be increased when Pancuronium is combined with Octopamine. Bevantolol Pancuronium may increase the bradycardic activities of Bevantolol.

Moricizine The risk or severity of adverse effects can be increased when Moricizine is combined with Pancuronium. These examples may contain rude words based on your search. CP The risk or severity of Tachycardia and drowsiness can be increased when Pancuronium is combined with CP Asenapine The risk or severity of adverse effects can be increased when Pancuronium is combined with Asenapine.

  CHUANG TZU BURTON WATSON PDF

Diltiazem Diltiazem may increase the neuromuscular blocking activities of Pancuronium. Granisetron The risk or severity of adverse effects can be increased when Granisetron is combined with Pancuronium.

Translation of “pancuronium bromide” in Spanish

Oxitriptan The risk or severity of adverse effects can be increased when Pancuronium is combined with Oxitriptan. Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Pancuronium.

Maprotiline The therapeutic efficacy of Maprotiline can be decreased when used in combination with Pancuronium.

Cafedrine The therapeutic efficacy of Pancuronium can be decreased when used in combination with Cafedrine. Magnesium citrate The therapeutic efficacy of Pancuronium can be increased when used in combination with Magnesium bronuro. Methyprylon The risk or severity of adverse effects can be increased when Methyprylon is combined with Pancuronium. Nitrazepam The risk or severity of adverse effects can be increased when Pancuronium is combined with Nitrazepam.

Methotrimeprazine Pancuronium may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine. Allobarbital The risk or severity of adverse effects can be increased when Pancuronium is combined with Allobarbital.